Wechsel Pharma Private Limited
About Wechsel Pharma Private Limited
Data last updated:
Wechsel Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 09 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC215514.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Geeta Gupta and Pankaj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 203 Sector 19 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.23 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹13.36 Lakh (net margin 6%) and EBITDA of ₹25.05 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹79.9 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 203 Sector 19 Dwarka, New Delhi, Delhi, India – 110075
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wechsel Pharma Private Limited
The main business activity of Wechsel Pharma is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wechsel Pharma Private Limited FY 2025 filings available
Wechsel Pharma Private Limited reported revenue of ₹2.23 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Wechsel Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 2% growth in the latest year. EBITDA rose 493% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wechsel Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wechsel Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wechsel Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Wechsel Pharma Private Limited
Wechsel Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prasad Ivf Clinic Private Limited | ₹2.26 Cr (FY 2023) | •••• | •••• | 52.0% | •••• | New Delhi, Delhi, India |
| Kumar Nursing Home and Maternity Centre Private Limited | ₹2.25 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Delhi, India |
| Nucare Health Private Limited | ₹2.24 Cr (FY 2023) | •••• | •••• | 1361.0% | •••• | Kaipamangalam, Kerala, India |
| Model Healthcare Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| SRM Critical Care Private Limited | ₹2.23 Cr (FY 2024) | •••• | •••• | •••• | Mandsaur, Madhya Pradesh, India | |
| Wechsel Pharma Private Limited this company | ₹2.23 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Astercare Wellness Private Limited | ₹2.23 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Nagpur, Maharashtra, India |
| Skipper Healthcare Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | -67.0% | •••• | Gurgaon, Haryana, India |
| Arete Care Private Limited | ₹2.23 Cr (FY 2024) | •••• | •••• | 56.0% | •••• | Angul, Odisha, India |
| Animani Healthcare Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Bathinda, Punjab, India |
| PCH Pharmacy Private Limited | ₹2.22 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Wechsel Pharma by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Wechsel Pharma Private Limited
Wechsel Pharma Private Limited is audited by ASHWANI KHANDELWAL & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASHWANI KHANDELWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Wechsel Pharma Private Limited
Wechsel Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Geeta Gupta | Director | 09 Mar 2011 | 15 Years 7 Months | Current |
| Pankaj Gupta | Director | 09 Mar 2011 | 15 Years 7 Months | Current |
| Girraj Prasad Gupta | Director | 02 Mar 2022 | 4 Years 7 Months | Current |
| Maya Gupta | Director | 02 Mar 2022 | 4 Years 7 Months | Current |
| Krishnam Gupta | Director | 02 Mar 2022 | 4 Years 7 Months | Current |
Ownership and Shareholding of Wechsel Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wechsel Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2024 | Canara Bank | ₹36.1 Lakh | Open |
| 18 Sep 2023 | Canara Bank | ₹43.8 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Wechsel Pharma Private Limited
Employment history and EPFO contributions of people linked to Wechsel Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wechsel Pharma Private Limited
Wechsel Pharma Private Limited has 7 board changes on record since 2011: 6 appointments and 1 cessation. The latest: Girraj Prasad Gupta was appointed as Director on 02 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts for Wechsel Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wechsel Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wechsel Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wechsel Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wechsel Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wechsel Pharma Private Limited
Wechsel Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 09 March 2011 (15+ years old) and is registered under CIN U24232DL2011PTC215514.
Wechsel Pharma reported revenue of ₹2.23 Cr for FY 2024 (up 2% YoY).
Wechsel Pharma has 5 current directors:
- Geeta Gupta - Director
- Pankaj Gupta - Director
- Girraj Prasad Gupta - Director
- Maya Gupta - Director
- Krishnam Gupta - Director
Wechsel Pharma reported a net profit of ₹13.36 Lakh (net margin 6%) and EBITDA of ₹25.05 Lakh (EBITDA margin 11.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wechsel Pharma is 30% over three years and 12% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Wechsel Pharma is U24232DL2011PTC215514. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wechsel Pharma was incorporated on 09 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Wechsel Pharma by revenue are Prasad Ivf Clinic Private Limited, Kumar Nursing Home and Maternity Centre Private Limited, Nucare Health Private Limited, Model Healthcare Private Limited, SRM Critical Care Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Girraj Prasad Gupta was appointed as Director on 02 Mar 2022. Krishnam Gupta was appointed as Director on 02 Mar 2022. Maya Gupta was appointed as Director on 02 Mar 2022. Wechsel Pharma has 7 board changes on record in total.
The registered office of Wechsel Pharma is at Plot No. 203 Sector 19 Dwarka, New Delhi, Delhi, India – 110075.
Wechsel Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh.